| pubmed-article:2020007 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2020007 | lifeskim:mentions | umls-concept:C0009170 | lld:lifeskim |
| pubmed-article:2020007 | lifeskim:mentions | umls-concept:C0927232 | lld:lifeskim |
| pubmed-article:2020007 | lifeskim:mentions | umls-concept:C0599851 | lld:lifeskim |
| pubmed-article:2020007 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:2020007 | lifeskim:mentions | umls-concept:C1551336 | lld:lifeskim |
| pubmed-article:2020007 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:2020007 | pubmed:dateCreated | 1991-5-24 | lld:pubmed |
| pubmed-article:2020007 | pubmed:abstractText | Cocaine was administered i.v. to decerebrate cats while monitoring cardiac preganglionic sympathetic nerve activity (SNA), arterial blood pressure (BP) and heart rate (HR). Cocaine, 4 mg/kg i.v., reduced SNA by 55 +/- 6%, but did not significantly affect BP or HR. Cocaine, in doses that were ineffective by the i.v. route, was administered into the vertebral artery and produced decreases in SNA, BP and HR in anesthetized cats. Administration of cocaine into the carotid artery was without effect. Topical administration of cocaine to the intermediate area of the ventrolateral medullary surface (25 micrograms/side) evoked hypotension and bradycardia. Nisoxetine, an inhibitor of norepinephrine uptake, applied bilaterally to the intermediate area (30 micrograms/side) exerted a similar hypotensive effect. Lidocaine administered in doses equivalent to those of cocaine had no significant effect on SNA when given i.v. or on BP when given into the vertebral artery. These results indicate that cocaine inhibits central sympathetic outflow and that the site of action appears to be in the hindbrain at a site that is reached by placement of the drug at the intermediate area of the ventrolateral medulla. The data also indicate that the mechanism of action of cocaine to inhibit sympathetic outflow may be unrelated to its local anesthetic action and may involve inhibition of catecholamine uptake in the ventrolateral medulla. | lld:pubmed |
| pubmed-article:2020007 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2020007 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2020007 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2020007 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2020007 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2020007 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2020007 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:2020007 | pubmed:issn | 0022-3565 | lld:pubmed |
| pubmed-article:2020007 | pubmed:author | pubmed-author:FriedmanEE | lld:pubmed |
| pubmed-article:2020007 | pubmed:author | pubmed-author:GillisR ARA | lld:pubmed |
| pubmed-article:2020007 | pubmed:author | pubmed-author:MandalA KAK | lld:pubmed |
| pubmed-article:2020007 | pubmed:author | pubmed-author:HamoshPP | lld:pubmed |
| pubmed-article:2020007 | pubmed:author | pubmed-author:QuestJ AJA | lld:pubmed |
| pubmed-article:2020007 | pubmed:author | pubmed-author:DretchenK LKL | lld:pubmed |
| pubmed-article:2020007 | pubmed:author | pubmed-author:AbrahamsT PTP | lld:pubmed |
| pubmed-article:2020007 | pubmed:author | pubmed-author:HernandezY... | lld:pubmed |
| pubmed-article:2020007 | pubmed:author | pubmed-author:ErzoukiH KHK | lld:pubmed |
| pubmed-article:2020007 | pubmed:author | pubmed-author:RaczkowskiV... | lld:pubmed |
| pubmed-article:2020007 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2020007 | pubmed:volume | 257 | lld:pubmed |
| pubmed-article:2020007 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2020007 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2020007 | pubmed:pagination | 511-9 | lld:pubmed |
| pubmed-article:2020007 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:2020007 | pubmed:meshHeading | pubmed-meshheading:2020007-... | lld:pubmed |
| pubmed-article:2020007 | pubmed:meshHeading | pubmed-meshheading:2020007-... | lld:pubmed |
| pubmed-article:2020007 | pubmed:meshHeading | pubmed-meshheading:2020007-... | lld:pubmed |
| pubmed-article:2020007 | pubmed:meshHeading | pubmed-meshheading:2020007-... | lld:pubmed |
| pubmed-article:2020007 | pubmed:meshHeading | pubmed-meshheading:2020007-... | lld:pubmed |
| pubmed-article:2020007 | pubmed:meshHeading | pubmed-meshheading:2020007-... | lld:pubmed |
| pubmed-article:2020007 | pubmed:meshHeading | pubmed-meshheading:2020007-... | lld:pubmed |
| pubmed-article:2020007 | pubmed:meshHeading | pubmed-meshheading:2020007-... | lld:pubmed |
| pubmed-article:2020007 | pubmed:meshHeading | pubmed-meshheading:2020007-... | lld:pubmed |
| pubmed-article:2020007 | pubmed:meshHeading | pubmed-meshheading:2020007-... | lld:pubmed |
| pubmed-article:2020007 | pubmed:meshHeading | pubmed-meshheading:2020007-... | lld:pubmed |
| pubmed-article:2020007 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:2020007 | pubmed:articleTitle | Cocaine acts in the central nervous system to inhibit sympathetic neural activity. | lld:pubmed |
| pubmed-article:2020007 | pubmed:affiliation | Department of Pharmacology, Georgetown University School of Medicine, Washington, DC. | lld:pubmed |
| pubmed-article:2020007 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2020007 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2020007 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2020007 | lld:pubmed |
